Abstract
Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.
Original language | English (US) |
---|---|
Pages (from-to) | 771 |
Number of pages | 1 |
Journal | Biotechnology Advances |
Volume | 15 |
Issue number | 3-4 |
DOIs | |
State | Published - 1997 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Applied Microbiology and Biotechnology